Buy Bristol-Myers on the dip?

12:27 PM ET Fri, 5 Aug 2016

CNBC's Meg Tirrell reports why Bristol-Myers shares are dropping while Merck shares are soaring. The “Fast Money Halftime Report” traders; Stephanie Link, TIAA Global Asset Management; and John Spallanzani, GFI Group chief macro strategist, discuss their views on buying Bristol-Myers on the dip.